These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25438737)

  • 1. Negative regulation of RelA phosphorylation: emerging players and their roles in cancer.
    Lu X; Yarbrough WG
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):7-13. PubMed ID: 25438737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPM1A is a RelA phosphatase with tumor suppressor-like activity.
    Lu X; An H; Jin R; Zou M; Guo Y; Su PF; Liu D; Shyr Y; Yarbrough WG
    Oncogene; 2014 May; 33(22):2918-27. PubMed ID: 23812431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
    Wang J; An H; Mayo MW; Baldwin AS; Yarbrough WG
    Cancer Cell; 2007 Sep; 12(3):239-51. PubMed ID: 17785205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
    Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
    Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway.
    Jamaluddin M; Wang S; Boldogh I; Tian B; Brasier AR
    Cell Signal; 2007 Jul; 19(7):1419-33. PubMed ID: 17317104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
    Nihira K; Ando Y; Yamaguchi T; Kagami Y; Miki Y; Yoshida K
    Cell Death Differ; 2010 Apr; 17(4):689-98. PubMed ID: 19911008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-kappaB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation.
    Choudhary S; Lu M; Cui R; Brasier AR
    Mol Endocrinol; 2007 Sep; 21(9):2203-17. PubMed ID: 17595324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling.
    Li S; Wang L; Berman MA; Zhang Y; Dorf ME
    Mol Cell; 2006 Nov; 24(4):497-509. PubMed ID: 17188031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.
    Gu Q; Kong Y; Yu ZB; Bai L; Xiao YB
    Biochimie; 2011 May; 93(5):909-20. PubMed ID: 21354254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of IκBα activates RelA to reduce acute pancreatitis in mice through up-regulation of Spi2A.
    Neuhöfer P; Liang S; Einwächter H; Schwerdtfeger C; Wartmann T; Treiber M; Zhang H; Schulz HU; Dlubatz K; Lesina M; Diakopoulos KN; Wörmann S; Halangk W; Witt H; Schmid RM; Algül H
    Gastroenterology; 2013 Jan; 144(1):192-201. PubMed ID: 23041330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond IkappaBs: alternative regulation of NF-kappaB activity.
    Neumann M; Naumann M
    FASEB J; 2007 Sep; 21(11):2642-54. PubMed ID: 17431096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways.
    Shi Y; Tu Z; Tang D; Zhang H; Liu M; Wang K; Calderwood SK; Xiao X
    Shock; 2006 Sep; 26(3):277-84. PubMed ID: 16912653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.
    Olson CM; Hedrick MN; Izadi H; Bates TC; Olivera ER; Anguita J
    Infect Immun; 2007 Jan; 75(1):270-7. PubMed ID: 17074860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.
    Campbell KJ; Witty JM; Rocha S; Perkins ND
    Cancer Res; 2006 Jan; 66(2):929-35. PubMed ID: 16424027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling.
    Wang Z; Liu D; Wang F; Liu S; Zhao S; Ling EA; Hao A
    Br J Nutr; 2012 Jan; 107(2):229-41. PubMed ID: 21733316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide activates ERK-PARP-1-RelA pathway and promotes nuclear factor-κB transcription in murine macrophages.
    Liu L; Ke Y; Jiang X; He F; Pan L; Xu L; Zeng X; Ba X
    Hum Immunol; 2012 May; 73(5):439-47. PubMed ID: 22391342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I
    Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.